Investor Overview

KindredBio is a biotechnology company that develops medicines for pets. We believe that our animal family members deserve the same great medicines that human family members enjoy.

Stock Information

NASDAQ CM$7.35
Change (%)0.00 (0.00%)
Volume58,118
Data as of 11/17/17 4:00 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.

NEWS

Kindred Biosciences Announces Third Quarter 2017 Financial Results

November 7, 2017

SAN FRANCISCO, Nov. 7, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K... 

Kindred Biosciences to Announce Third Quarter 2017 Financial Results

October 11, 2017

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m... 

Kindred Biosciences to Participate in the Oppenheimer & Co. Specialty Pharmaceuticals Conference

October 5, 2017

SAN FRANCISCO, Oct. 5, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...